Zhang Xizhou, Wu Jinyao, Yang Qiuping, Tian Huiting, Chen Lingzhi, Zheng Daitian, Ji Zeqi, Cai Jiehui, Chen Yexi, Li Zhiyang
Department of Thyroid, Breast and Hernia Surgery, General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Front Oncol. 2023 Aug 10;13:1167154. doi: 10.3389/fonc.2023.1167154. eCollection 2023.
Over the past decade, thousands of articles have been published on the mechanistic target of rapamycin (mTOR) and its role in breast cancer. However, the variability and heterogeneity of academic data may impact the acquisition of published research information. Due to the large number, heterogeneity, and varying quality of publications related to mTOR and breast cancer, sorting out the present state of the research in this area is critical for both researchers and clinicians. Therefore, scientometric techniques and visualization tools were employed to analyze the large number of bibliographic metadata related to the research area of mTOR and breast cancer. The features of relevant publications were searched from 2012 to 2022 to evaluate the present status of research and the evolution of research hotspots in this particular field. Web of Science was utilized to extract all relevant publications from 2012 to 2022. Subsequently, Biblioshiny and VOSviewer were utilized to obtain data on the most productive countries, authors, and institutions, annual publications and citations, the most influential journals and articles, and the most frequently occurring keywords. In total, 1,471 publications were retrieved, comprising 1,167 original articles and 304 reviews. There was a significant rise in publications between 2015 and 2018, followed by a sharp decline in 2019 and a rebound since then. The publication with the highest number of citations was a 2012 review authored by Baselga et al. The United States had the highest number of publications, citations and connections among all countries. Oncotarget had the highest number of published articles among all the journals, and José Baselga had the strongest links with other authors. Excluding the search topics, the most frequently used words were "expression" (n = 297), "growth" (n = 228), "activation" (n = 223), "pathway" (n = 205), and "apoptosis" (n = 195). mTOR is crucially involved in breast cancer pathogenesis, but its exact mechanism of action remains controversial and warrants further investigation. The scientometric analysis provides a distinct overview of the existing state of research and highlights the topical issues that deserve further exploration.
在过去十年中,已经发表了数千篇关于雷帕霉素的作用机制靶点(mTOR)及其在乳腺癌中作用的文章。然而,学术数据的可变性和异质性可能会影响已发表研究信息的获取。由于与mTOR和乳腺癌相关的出版物数量众多、异质性强且质量参差不齐,梳理该领域的研究现状对研究人员和临床医生都至关重要。因此,采用科学计量学技术和可视化工具来分析与mTOR和乳腺癌研究领域相关的大量文献元数据。检索了2012年至2022年相关出版物的特征,以评估该特定领域的研究现状和研究热点的演变。利用科学网(Web of Science)提取了2012年至2022年的所有相关出版物。随后,使用Biblioshiny和VOSviewer来获取关于产出最多的国家、作者和机构、年度出版物和引用情况、最具影响力的期刊和文章以及最常出现的关键词的数据。总共检索到1471篇出版物,其中包括1167篇原创文章和304篇综述。2015年至2018年期间出版物数量显著增加,随后在2019年急剧下降,此后又有所反弹。被引用次数最多的出版物是2012年由巴塞尔加等人撰写的一篇综述。在所有国家中,美国的出版物、引用次数和联系数量最多。在所有期刊中,《肿瘤靶向》(Oncotarget)发表的文章数量最多,何塞·巴塞尔加与其他作者的联系最为紧密。除搜索主题外,最常用的词汇是“表达”(n = 297)、“生长”(n = 228)、“激活”(n = 223)、“信号通路”(n = 205)和“凋亡”(n = 195)。mTOR在乳腺癌发病机制中起着关键作用,但其确切作用机制仍存在争议,值得进一步研究。科学计量学分析提供了对现有研究状态的清晰概述,并突出了值得进一步探索的热点问题。